Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Mar;14(1):1-8.
doi: 10.1007/s12253-008-9018-z. Epub 2008 Apr 12.

Lapatinib: a sword with two edges

László Kopper  1
Affiliations
Free article
Review

Lapatinib: a sword with two edges

László Kopper. Pathol Oncol Res. 2008 Mar.
Free article

Abstract

Lapatinib is an oral dual tyrosine kinase inhibitor targeting EGFR1 and EGFR2 (HER2). Phase I trials have shown that lapatinib is well tolerated, with mild diarrhea and skin rush as common adverse effects, and low cardiotoxicity. Phase II and III trials provided evidences on clinical effectiveness in advanced or metastatic breast cancer and potential against brain metastases. Lapatinib is active in combination with trastuzumab and in trastuzumab-resistant patients, moreover it has synergistic action with capecitabine. Several clinical trials are in progress to explore the effectiveness of lapatinib in other combinations and against several tumor types.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Res. 2006 Feb 1;66(3):1630-9 - PubMed
    1. Science. 1987 Jan 9;235(4785):177-82 - PubMed
    1. Urology. 2007 Feb;69(2):390-4 - PubMed
    1. Cancer Res. 2004 Sep 15;64(18):6652-9 - PubMed
    1. J Natl Cancer Inst. 2007 Mar 7;99(5):348-9 - PubMed

MeSH terms